Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Alcohol Dependence in Bipolar I Disorder
NCT00114686Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in alcohol dependence, sponsored by AstraZeneca. Started Jan 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00114686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114686.